Compound: Lestaurtinib

Drug Target: FLT3, JAK2, NTRK1, NTRK2, NTRK3

Drug Target pathway: Other, kinases

DatasetDatasets
GDSC1: Screened in 96 or 384-well plates with Cyto60 or Resazurin endpoint
GDSC2 (recommended where available): 1536-well plates with CellTiterGlo endpoint
See documentation for more information and screening differences



Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.